Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.5 EUR | +2.30% | -2.46% | -24.80% |
04-26 | COMPUGROUP MEDICAL : Buy rating from Baader Bank | ZD |
04-25 | COMPUGROUP MEDICAL : Jefferies gives a Neutral rating | ZD |
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Analyst opinion has improved significantly over the past four months.
Weaknesses
- The group shows a rather high level of debt in proportion to its EBITDA.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-24.80% | 1.59B | C+ | ||
+11.17% | 322B | B- | ||
+24.75% | 216B | B+ | ||
+2.41% | 149B | B | ||
+10.65% | 56.27B | D+ | ||
+8.71% | 32.13B | B+ | ||
-4.57% | 27.45B | C+ | ||
+103.03% | 22.62B | D+ | ||
+20.22% | 19.55B | B- | ||
+13.06% | 14.69B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- COP Stock
- Ratings CompuGroup Medical SE & Co. KGaA